<a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/2179308/open_sms">Send us a text</a>Dr. Del Rosso discusses three exciting new indications for drugs in dermatology and how these approvals will impact clinical practice.

Send us a text Dr. Del Rosso discusses three exciting new indications for drugs in dermatology and how these approvals will impact clinical practice.

<a href="https://www.buzzsprout.com/twilio/text_messages/2179308/open_sms" rel="noopener noreferrer">Send us a text</a>Dr. Del Rosso discusses three exciting new indications for drugs in dermatology and how these approvals will impact clinical practice.&nbsp;

James Del Rosso, DO: New and Exciting Indications for Bimekizumab, Nemolizumab, and Lebrikizumab

JCAD's audio platform provides interviews with leading experts in the dermatology field.&nbsp;

Medicine

Health & Fitness

JCAD's audio platform provides interviews with leading experts in the dermatology field. 

Share James Del Rosso, DO: New and Exciting Indications for Bimekizumab, Nemolizumab, and Lebrikizumab

Sign up to save your podcasts

James Del Rosso, DO: New and Exciting Indications for Bimekizumab, Nemolizumab, and Lebrikizumab

James Del Rosso, DO: New and Exciting Indications for Bimekizumab, Nemolizumab, and Lebrikizumab

More shows like The Journal of Clinical and Aesthetic Dermatology

Emergency Medicine Cases

EADV Podcast

Derms on Drugs